Amgen is shaking up R&D (again), chopping 200 as Genentech targets 130 layoffs
Two biotech giants — Amgen and Genentech — are laying off a combined 330 people at California facilities, both citing “organizational changes” as the primary reason for the cuts.
Amgen is shaking up its R&D department, eliminating 200 positions at its Thousand Oaks, CA and South San Francisco facilities by the end of this year, STAT reported Saturday. An Amgen spokesperson tells me the company is making organizational changes across the globe in regards to its R&D departments. This round of layoffs, however, mostly impacts facilities in California.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.